Efficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphoma

Leuk Lymphoma. 2019 Mar;60(3):833-835. doi: 10.1080/10428194.2018.1504938. Epub 2018 Sep 20.

Authors

Emanuele Cencini¹, Alberto Fabbri¹, Luana Schiattone¹, Monica Bocchia¹

Affiliation

¹ a Unit of Hematology , Azienda Ospedaliera Universitaria Senese , Siena , Italy.

PMID: 30234387
DOI: 10.1080/10428194.2018.1504938

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bendamustine Hydrochloride / administration & dosage
Biopsy
Gastroscopy
Humans
Lymphoma, B-Cell, Marginal Zone / diagnosis
Lymphoma, B-Cell, Marginal Zone / drug therapy*
Neoplasm Grading
Neoplasm Staging
Retrospective Studies
Rituximab / administration & dosage
Stomach Neoplasms / diagnosis
Stomach Neoplasms / drug therapy*
Tomography, X-Ray Computed
Treatment Outcome

Substances

Rituximab
Bendamustine Hydrochloride